{
  "abstract": "The “What you need to know” box of this Practice Pointer by Rebecca Burch and Eve Rittenberg (BMJ 2025;390:e085564, doi:10.1136/bmj-2025-085564) originally stated that ditans were serotonin receptor antagonists. The online article has now been corrected to say that ditans are serotonin receptor agonists.",
  "authors": [
    {
      "affiliations": [],
      "name": "British Medical Journal Publishing Group"
    }
  ],
  "title": "New treatments for migraine: CGRP monoclonal antibodies, gepants, and ditans",
  "uid": "f11f2823-ca89-5be7-a67b-3f8f8bd5a365"
}